1. Home
  2. OP vs IBO Comparison

OP vs IBO Comparison

Compare OP & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • IBO
  • Stock Information
  • Founded
  • OP 2021
  • IBO 2018
  • Country
  • OP Greece
  • IBO United States
  • Employees
  • OP N/A
  • IBO N/A
  • Industry
  • OP
  • IBO
  • Sector
  • OP
  • IBO
  • Exchange
  • OP Nasdaq
  • IBO NYSE
  • Market Cap
  • OP 6.0M
  • IBO 5.1M
  • IPO Year
  • OP N/A
  • IBO 2024
  • Fundamental
  • Price
  • OP $0.71
  • IBO $0.47
  • Analyst Decision
  • OP
  • IBO
  • Analyst Count
  • OP 0
  • IBO 0
  • Target Price
  • OP N/A
  • IBO N/A
  • AVG Volume (30 Days)
  • OP 17.2K
  • IBO 505.3K
  • Earning Date
  • OP 06-17-2025
  • IBO 06-13-2025
  • Dividend Yield
  • OP N/A
  • IBO N/A
  • EPS Growth
  • OP N/A
  • IBO N/A
  • EPS
  • OP N/A
  • IBO N/A
  • Revenue
  • OP $25,702,000.00
  • IBO N/A
  • Revenue This Year
  • OP N/A
  • IBO N/A
  • Revenue Next Year
  • OP N/A
  • IBO N/A
  • P/E Ratio
  • OP N/A
  • IBO N/A
  • Revenue Growth
  • OP 35.58
  • IBO N/A
  • 52 Week Low
  • OP $0.63
  • IBO $0.37
  • 52 Week High
  • OP $2.26
  • IBO $6.17
  • Technical
  • Relative Strength Index (RSI)
  • OP 41.26
  • IBO N/A
  • Support Level
  • OP $0.70
  • IBO N/A
  • Resistance Level
  • OP $0.78
  • IBO N/A
  • Average True Range (ATR)
  • OP 0.04
  • IBO 0.00
  • MACD
  • OP -0.00
  • IBO 0.00
  • Stochastic Oscillator
  • OP 7.50
  • IBO 0.00

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

About IBO IMPACT BIOMEDICAL INC

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Share on Social Networks: